Savannah Elkins
Physician Assistant · Fort Worth, TXNPI 1841927423
Payments from drug & device makers
Across 268 payments — averaging $20.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$744
- Dexcom, Inc.$636
- Lilly USA, LLC$524
- Amgen$382
- Insulet Corporation$355
- Xeris Pharmaceuticals, Inc.$279
- plus $3K from 28 others
What the payments were for
- Food & beverage$5,448100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 41 | $744 |
| Dexcom, Inc. | 32 | $636 |
| Lilly USA, LLC | 29 | $524 |
| Amgen(2 entities) | 15 | $382 |
| Insulet Corporation | 10 | $355 |
| Xeris Pharmaceuticals, Inc. | 11 | $279 |
| Neurocrine Biosciences, Inc. | 6 | $259 |
| AstraZeneca(2 entities) | 12 | $254 |
| Boehringer Ingelheim | 17 | $243 |
| Sanofi-aventis U.S. LLC | 12 | $217 |
| Sequel Med Tech, LLC | 12 | $205 |
| Nevro Corp. | 6 | $126 |
| Abbott | 6 | $123 |
| Mannkind Corporation | 5 | $88 |
| Novartis | 3 | $79 |
| Pfizer | 4 | $78 |
| Tandem Diabetes Care, Inc. | 5 | $78 |
| Tolmar, Inc. | 4 | $74 |
| Amarin Pharma, Inc. | 3 | $71 |
| Corcept Therapeutics | 3 | $67 |
| BETA Bionics, Inc. | 4 | $61 |
| IBSA Pharma Inc. | 3 | $60 |
| Amneal Pharmaceuticals LLC | 3 | $57 |
| Alvogen Inc | 3 | $56 |
| Cequr Corporation | 3 | $49 |
| AbbVie | 3 | $48 |
| Chiesi USA, Inc. | 2 | $41 |
| Halozyme Inc | 2 | $37 |
| Medtronic | 2 | $34 |
| Acella Pharmaceuticals, LLC | 2 | $33 |
| Bayer | 2 | $31 |
| Madrigal Pharmaceuticals | 1 | $31 |
| Recordati_rare_diseases_inc. | 1 | $16 |
| Radius Health, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnipod$145
- RECORLEV$133
- CRENESSITY$123
- Ozempic$111
How this compares
$5,448 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 232 | $278,460 |
| MounjaroTirzepatide | 119 | $158,041 |
| JardianceEmpagliflozin | 135 | $140,857 |
| TrulicityDulaglutide | 65 | $106,425 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 77 | $99,063 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 87 | $96,338 |
| Tresiba Flextouch U-100Insulin Degludec | 45 | $68,582 |
| FarxigaDapagliflozin Propanediol | 38 | $45,598 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 23 | $45,065 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 38 | $39,683 |
| Tresiba Flextouch U-200Insulin Degludec | 15 | $38,335 |
| SynjardyEmpagliflozin/Metformin Hcl | 24 | $30,381 |
| NovologInsulin Aspart | 27 | $15,567 |
| Humalog Kwikpen U-100Insulin Lispro | 48 | $14,792 |
| HumalogInsulin Lispro | 50 | $13,152 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Novolog | $744 | $294,027259 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro | $524 | $279,555246 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Synjardy | $243 | $210,922197 claims |
| AstraZenecaFarxiga | $254 | $45,59838 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $217 | $45,06523 claims |
| AbbVieSynthroid | $48 | $6,88670 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $57 | $898103 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in Fort Worth
- Tara HallFort Worth$44K
- Amanda DuckFort Worth$43K
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Anthony DerenciusSan Antonio$507K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.